Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies

Epilepsy Research

Volumn 40, Issue 1, 2000, Pages 33-39

  Ben Menachem, Elinor ^a   Kyllerman, Mårten ^a   Marklund, Stefan ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antioxidant therapy; Glutathione; Progressive myoclonus epilepsy; Superoxide dismutase

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CARBAMAZEPINE; CATALASE; CLONAZEPAM; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; PRIMIDONE; SUPEROXIDE DISMUTASE; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; ENZYME BLOOD LEVEL; ERYTHROCYTE LEVEL; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETYLCYSTEINE; ADULT; EPILEPSIES, MYOCLONIC; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LAFORA DISEASE; MALE; REFERENCE VALUES; SUPEROXIDE DISMUTASE; UNVERRICHT-LUNDBORG SYNDROME;

EID: 0034212315     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00096-6     Document Type: Article

References (23)

1. Eldridge R., Iivanainen M., Stern R., Joerber T., Wilder B.J. 'Baltic' myoclonic epilepsy: h hereditary disorder of childhood made worse by phenytoin. Lancet. 2:1983;838-842.
2. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49:1993;577-587.
3. Hardell L., Danell M., Ängquist C.-A., Marklund S.L., Fredriksson M., Zakari A.-L., Kjellgren A. Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer, a case-control study. Biol. Trace Elem. Res. 36:1993;99-108.
4. Hurd R.W., Wilder B.J., Perchalski B.J. Increased extracellular superoxide dismutase in Baltic myoclonus. Epilepsia. 34(Suppl. 2):1993;14-15.
5. Hurd R.W., Wilder B.J., Helveston R.W., Uthman B.M. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurology. 47:1996;1264-1268.
6. Karlsson K., Marklund S.L. Plasma clearance of human extracellular-superoxide dismutase C in rabbits. J. Clin. Invest. 82:1988;762-766.
7. Kyllerman M., Sommerfeldt K., Hedström A., Wennergren G., Holmgren D. Clinical and neurophysiological development of Univerricht-Lundborg disease in four Swedish siblings. Epilepsia. 32:1991;900-909.
8. Lafreniere R.G., Rochefort D.L., Chretien N., Rommens J.M., Cochius J.I., Kalviainen R., Nousiainen U., Patry G., Farrell K., Soderfeldt B., Federico A., Hale B.R., Cossio O.H., Sorensen T., Pouliot M.A., Kmiec T., Uldall P., Janszky J., Pranzatelli M.R., Andermann F., Andermann E., Rouleau G.A. Unstable insertion of the 5-prime flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat. Genet. 15:1997;298-302.
9. Lehesjoki A.E., Koskiniemi M., Pandolfo M., Antonielli A., Kyllerman M. et al. Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's disease. Neurology. 42:1992;1545-1550.
10. Levanon D., Lieman-Hurwitz J., Dafni W. et al. Architecture and anatomy of the chromosomal locus in himan chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 4:1985;77-84.
11. Lundborg H, 1901. Klinische studien und erfahrungen hinsichtlich der familiaren myoklonie und damit verwandter krankheiten. Stockholm: Issac Marcus Boktr-Aktiebolag.
12. Maertens P., Dyken P., Graf W., Pippenger C., Chronister R., Shah A. Free radicals, anticonvulsants and the neuronal ceroid-lipofuscinoses. Am. J. Med. Genet. 57:1995;225-228.
13. Mahle C., Dasgupta A. Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci. 61:1997;437-443.
14. Marklund S.L. A spectrophotometric study of the spontaneous disproportionation of the superoxide anion radical, and a sensitive direct assay for superoxide dismutase. J. Biol. Chem. 251:1976;7504-7507.
15. Marklund S.L., Westman G., Lundgren E., Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42:1982;1955-1961.
16. Marklund S.L., Andersson P.M., Forsgren L., Nilsson P., Nilsson P.-J., Wiklander G., Öberg A. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem. 69:1997;675-681.
17. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J. et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy. Science. 271:1996;1731-1734.
18. Poirer J., Thiffault C. Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease? Eur. Neurol. 33(Suppl. 1):1993;38-43.
19. Rothstein, J.D., Bristol, L.A., Hosler, B., Brown, R.H., Kunel, R.W., 1995. Chronic inhibition of superoxide dismutase produces apopotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91, 4155-5195.
20. Santavuori P., Westermarck T., Rapola J., Pohja P., Moren R., Lappi M., Vuonnala U. Antioxidant treatment in Spielmeyer-Sjögren's disease. Acta Neurol. Scand. 71:1985;136-145.
21. Serratosa J.M., Delgado-Escueta A., Posada I., Shih S., Drury I., Berciano J., Zabala J.A., Sparkes R.S. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosone 6q. Hum. Mol. Genet. 4:1995;1657-1663.
22. Ueda Y., Yokoyama H., Niwa R., Konaka R., Ohya-Nishiguchi H., Kamada H. Generation of lipid radicals in the hippocampis extracellular space during kainic acid-induced seizures in rats. Epilepsy Res. 26:1997;329-333.
23. Yanakawa, K., Mitchell, S., Hubert, R., Chen, X.N., Colbern, S., Y.-K., et al., 1995. Isolation and characterization of a candidate gene for progress myoclonus epilepsy on 21q22.3. Hum. Mol. Genet. 4, 709-716.